1. Home
  2. ECOR vs PFO Comparison

ECOR vs PFO Comparison

Compare ECOR & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo electroCore Inc.

ECOR

electroCore Inc.

SELL

Current Price

$9.62

Market Cap

100.3M

Sector

Health Care

ML Signal

SELL

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

SELL

Current Price

$8.53

Market Cap

118.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ECOR
PFO
Founded
2005
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
100.3M
118.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ECOR
PFO
Price
$9.62
$8.53
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $19.17
N/A
AVG Volume (30 Days)
★ 79.7K
30.3K
Earning Date
11-04-2026
01-01-0001
Dividend Yield
N/A
★ 6.51%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $32,032,000.00
N/A
Revenue This Year
$30.85
N/A
Revenue Next Year
$29.71
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 27.20
N/A
52 Week Low
$4.41
$8.46
52 Week High
$12.70
$9.81

Technical Indicators

Market Signals
Indicator
ECOR
PFO
Relative Strength Index (RSI) 40.72 33.64
Support Level $8.63 N/A
Resistance Level $9.53 $9.24
Average True Range (ATR) 0.61 0.09
MACD -0.24 -0.00
Stochastic Oscillator 4.71 25.51

Price Performance

Historical Comparison
ECOR
PFO

About ECOR electroCore Inc.

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: